drugset / Trial / NCT00002916
Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
Treatment
Summary
RATIONALE: Vaccines made from human papillomavirus may make the body build an immune response to and kill cervical cancer cells. Combining vaccine therapy with surgery may be a more effective treatment for cervical cancer. PURPOSE: This phase II trial is studying how well giving vaccine therapy together with surgery works in treating patients with early cervical cancer.
Timeline
- Start
- 1996-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human papillomavirus 16 E7 peptide | Peptide | — | — |
| Subject | synthetic human papillomavirus 16 E6 peptide | Peptide | — | — |